‘Opioids’ Is Missing From The US FDA’s Overdose Prevention Framework Title On Purpose

divergent path
The Overdose Prevention Framework diverges from previous substance abuse plans, which were focused on opioids. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership